An enormously expanded group of various amino acid transporters.. Localization: Cell surface (by feature)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: E9AHD8
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.224 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.224 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.206 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.415 |
DOC_MAPK_FxFP_2 | 215 | 218 | PF00069 | 0.308 |
DOC_MAPK_gen_1 | 19 | 27 | PF00069 | 0.206 |
DOC_MAPK_MEF2A_6 | 41 | 50 | PF00069 | 0.203 |
DOC_PP2B_LxvP_1 | 193 | 196 | PF13499 | 0.327 |
DOC_PP2B_PxIxI_1 | 195 | 201 | PF00149 | 0.290 |
DOC_PP4_FxxP_1 | 215 | 218 | PF00568 | 0.302 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.239 |
DOC_WW_Pin1_4 | 82 | 87 | PF00397 | 0.392 |
LIG_14-3-3_CanoR_1 | 49 | 58 | PF00244 | 0.288 |
LIG_14-3-3_CanoR_1 | 88 | 92 | PF00244 | 0.514 |
LIG_BRCT_BRCA1_1 | 208 | 212 | PF00533 | 0.233 |
LIG_BRCT_BRCA1_1 | 239 | 243 | PF00533 | 0.386 |
LIG_EH1_1 | 25 | 33 | PF00400 | 0.341 |
LIG_eIF4E_1 | 104 | 110 | PF01652 | 0.306 |
LIG_FHA_1 | 239 | 245 | PF00498 | 0.231 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.256 |
LIG_LIR_Gen_1 | 159 | 169 | PF02991 | 0.425 |
LIG_LIR_Gen_1 | 219 | 224 | PF02991 | 0.206 |
LIG_LIR_Gen_1 | 240 | 250 | PF02991 | 0.284 |
LIG_LIR_Gen_1 | 63 | 74 | PF02991 | 0.292 |
LIG_LIR_Gen_1 | 76 | 86 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 159 | 165 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 209 | 215 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 21 | 26 | PF02991 | 0.261 |
LIG_LIR_Nem_3 | 232 | 238 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 240 | 246 | PF02991 | 0.266 |
LIG_LIR_Nem_3 | 258 | 264 | PF02991 | 0.359 |
LIG_LIR_Nem_3 | 63 | 69 | PF02991 | 0.257 |
LIG_LYPXL_S_1 | 216 | 220 | PF13949 | 0.284 |
LIG_MLH1_MIPbox_1 | 239 | 243 | PF16413 | 0.206 |
LIG_NRBOX | 11 | 17 | PF00104 | 0.392 |
LIG_PALB2_WD40_1 | 231 | 239 | PF16756 | 0.392 |
LIG_PAM2_1 | 185 | 197 | PF00658 | 0.206 |
LIG_PCNA_yPIPBox_3 | 176 | 184 | PF02747 | 0.419 |
LIG_Pex14_2 | 101 | 105 | PF04695 | 0.296 |
LIG_Pex14_2 | 208 | 212 | PF04695 | 0.318 |
LIG_Pex14_2 | 23 | 27 | PF04695 | 0.377 |
LIG_Pex14_2 | 64 | 68 | PF04695 | 0.343 |
LIG_SH2_CRK | 127 | 131 | PF00017 | 0.255 |
LIG_SH2_CRK | 162 | 166 | PF00017 | 0.447 |
LIG_SH2_PTP2 | 139 | 142 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.228 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.235 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.243 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.412 |
LIG_TRAF2_1 | 77 | 80 | PF00917 | 0.392 |
LIG_TYR_ITIM | 137 | 142 | PF00017 | 0.262 |
LIG_TYR_ITIM | 24 | 29 | PF00017 | 0.309 |
LIG_WRC_WIRS_1 | 169 | 174 | PF05994 | 0.403 |
LIG_WRC_WIRS_1 | 217 | 222 | PF05994 | 0.416 |
LIG_WRC_WIRS_1 | 61 | 66 | PF05994 | 0.338 |
MOD_CDK_SPxK_1 | 82 | 88 | PF00069 | 0.392 |
MOD_CK1_1 | 229 | 235 | PF00069 | 0.447 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.346 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.460 |
MOD_CK2_1 | 74 | 80 | PF00069 | 0.284 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.559 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.244 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.242 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.580 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.331 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.476 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.304 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.417 |
MOD_N-GLC_1 | 226 | 231 | PF02516 | 0.247 |
MOD_N-GLC_2 | 177 | 179 | PF02516 | 0.206 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.367 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.288 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.457 |
MOD_PIKK_1 | 67 | 73 | PF00454 | 0.206 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.487 |
MOD_Plk_1 | 226 | 232 | PF00069 | 0.412 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.274 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.499 |
MOD_Plk_4 | 238 | 244 | PF00069 | 0.374 |
MOD_Plk_4 | 256 | 262 | PF00069 | 0.171 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.343 |
MOD_ProDKin_1 | 82 | 88 | PF00069 | 0.392 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.343 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.322 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.360 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.397 |
TRG_ER_diArg_1 | 18 | 20 | PF00400 | 0.224 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NDW9 | Trypanosomatidae | 41% | 100% |
A0A1X0NNV8 | Trypanosomatidae | 50% | 100% |
A0A3Q8IN54 | Leishmania donovani | 25% | 82% |
A0A451EJH9 | Leishmania donovani | 38% | 89% |
E9B1I3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 50% | 100% |
V5DET2 | Trypanosoma cruzi | 57% | 75% |